- Home
- COCP vs ALUR Comparison
COCP vs ALUR Comparison
Compare COCP & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- ALUR
- Stock Information
- Founded
- COCP N/A
- ALUR 2009
- Country
- COCP United States
- ALUR United States
- Employees
- COCP N/A
- ALUR N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- ALUR
- Sector
- COCP Health Care
- ALUR
- Exchange
- COCP Nasdaq
- ALUR Nasdaq
- Market Cap
- COCP 20.1M
- ALUR 22.5M
- IPO Year
- COCP N/A
- ALUR N/A
- Fundamental
- Price
- COCP $1.98
- ALUR $2.93
- Analyst Decision
- COCP Strong Buy
- ALUR Strong Buy
- Analyst Count
- COCP 1
- ALUR 4
- Target Price
- COCP $7.00
- ALUR $75.00
- AVG Volume (30 Days)
- COCP 93.7K
- ALUR 101.1K
- Earning Date
- COCP 11-13-2024
- ALUR 11-13-2024
- Dividend Yield
- COCP N/A
- ALUR N/A
- EPS Growth
- COCP N/A
- ALUR N/A
- EPS
- COCP N/A
- ALUR N/A
- Revenue
- COCP N/A
- ALUR $34,754,000.00
- Revenue This Year
- COCP N/A
- ALUR N/A
- Revenue Next Year
- COCP N/A
- ALUR $2.22
- P/E Ratio
- COCP N/A
- ALUR N/A
- Revenue Growth
- COCP N/A
- ALUR N/A
- 52 Week Low
- COCP $1.33
- ALUR $2.37
- 52 Week High
- COCP $3.26
- ALUR $98.75
- Technical
- Relative Strength Index (RSI)
- COCP 44.30
- ALUR 27.81
- Support Level
- COCP $2.21
- ALUR $2.72
- Resistance Level
- COCP $2.60
- ALUR $4.20
- Average True Range (ATR)
- COCP 0.33
- ALUR 1.92
- MACD
- COCP -0.07
- ALUR -0.52
- Stochastic Oscillator
- COCP 4.81
- ALUR 4.95
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.